We are live on
!
Find out more
MCAV
Meritech Capital Associates V Portfolio holdings
AUM
$141M
1-Year Est. Return
15.44%
This Fund
S&P 500
This Quarter
Est. Return
-4.93%
1 Year Est. Return
+15.44%
3 Year Est. Return
+37.35%
5 Year Est. Return
+8.8%
10 Year Est. Return
–
AUM
$4.05B
AUM Growth
+$2.86B
(+240%)
Cap. Flow
+$3.11B
Cap. Flow
% of AUM
76.83%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roblox
RBLX
|
+$3.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 73.28% |
| 2 | Technology | 17.24% |
| 3 | Healthcare | 9.49% |
Similar funds
CL
SFS
CFGW
OFA
RB
KCM
WA
TM
Meritech Capital Associates V's Q1 2021 Portfolio in Review
As of Q1 2021, Meritech Capital Associates V held 3 positions worth $4.05B, up 240% from $1.19B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Meritech Capital Associates V deployed $3.11B of net new capital in Q1 2021, opening 1 new position. Its largest new stake was Roblox: 45,799,284 shares worth $2.97B.
By sector, the portfolio is most concentrated in Communication Services at 73% of assets, followed by Technology and Healthcare.
On the sell side, the largest reduction was 10x Genomics, an estimated $79M trimmed.
- Meritech Capital Associates V's largest Q1 2021 buy was Roblox: 45,799,284 shares worth $2.97B.
- Meritech Capital Associates V's biggest Q1 2021 reduction was 10x Genomics, cutting an estimated $79M.
- Meritech Capital Associates V's ten largest holdings make up 100% of its $4.05B portfolio in Q1 2021.
- Meritech Capital Associates V opened 1 new position and closed 0 in Q1 2021.
- Meritech Capital Associates V's portfolio value rose 240% quarter-over-quarter to $4.05B.
Based on Meritech Capital Associates V's 13F filing for Q1 2021, filed 17 May 2021.